Latest Schedule 13G passive stakes

Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have entered into a joint filing agreement concerning their beneficial ownership of Capricor Therapeutics, Inc. common stock.

Jorey Chernett has filed a Schedule 13G, reporting beneficial ownership of 2,339,009 American Depositary Shares, representing 19.6% of the outstanding class in Kazia Therapeutics Ltd.

Millennium Management LLC, along with affiliated entities and Israel A. Englander, has reported beneficial ownership of 5.6% of Vanda Pharmaceuticals Inc. common stock.

William T. Walters, The Walters Group, and Susan B. Walters report a combined beneficial ownership of 18.8% in Zentalis Pharmaceuticals, Inc., reflecting shared voting and dispositive power.

Millennium Management LLC, along with affiliated entities and Israel A. Englander, has reported beneficial ownership of 5.5% of T1 Energy Inc.'s common stock.

Daniel Louis Kaufman has reported beneficial ownership of 5,956,714 shares, representing 5.9% of Stereotaxis, Inc.'s common stock, as of August 12, 2026.

Investment firm Pertento Partners LLP, along with its affiliates, has reported beneficial ownership of 5.6% of Grocery Outlet Holding Corp.'s common stock.

YR Sea Group Pte. Ltd. and Junwu Hu have jointly filed a Schedule 13G, reporting beneficial ownership of 8.72% of iOThree Limited's ordinary shares.

A Schedule 13G filing reveals beneficial ownership details for iOThree Limited's ordinary shares by Jun Li and associated entities.

Saba Capital Management, L.P. and its affiliates have reported beneficial ownership of 5.11% of AVAX One Technology Ltd.'s common shares.

Strategic Value Investors LP and affiliated entities have reported a 3.9% ownership stake in SB Financial Group, Inc. as of June 30, 2026.

Jane Street Group, LLC, along with its subsidiaries Jane Street Capital, LLC and Jane Street Global Trading, LLC, has reported beneficial ownership of 7.2% of C3is Inc. common stock.

L.I.A. Pure Capital Ltd. and Xylo Technologies Ltd. have jointly filed a Schedule 13G, reporting their beneficial ownership of Quantum X Labs Inc. common stock.

Point72 Asset Management, Point72 Capital Advisors, and Steven A. Cohen jointly filed a Schedule 13G, reporting beneficial ownership of 6.0% of RxSight, Inc. common stock.

Alta Partners LLC has reported beneficial ownership of 687,321 shares, representing 8.4% of BioVie Inc.'s Class A Common Stock, acquired via warrants.

Nexera Technologies Ltd. has disclosed beneficial ownership of 11,416,863 common shares, representing 72.53% of Fort Technology Inc., with certain restrictions on further acquisition.

Nexera Technologies Ltd. has disclosed beneficial ownership of 11,416,863 common shares, representing 72.53% of Fort Technology Inc., with certain restrictions on further acquisition.

Terry LaCore has filed an amendment to Schedule 13G, confirming beneficial ownership of 159,585 shares of Mannatech Inc. common stock, representing 8.3% of the class.

CVI Investments, Inc. and Heights Capital Management, Inc. have jointly filed a Schedule 13G, reporting beneficial ownership of 9.9% of Outlook Therapeutics, Inc. common stock.

Terry LaCore has filed an amendment to a Schedule 13G, reporting an 8.27% beneficial ownership of Mannatech Inc. common stock as of June 30, 2026.

H2O America's Schedule 13G filing is amended to correct reporting designations, confirming ATLAS Infrastructure Partners (UK) Ltd. and GIP Atlas Holdings Limited collectively hold 11.03% of common stock.

Imperial Vision Fund SPC Series 1 SP has reported the sale of all its Class A ordinary shares in Dreamland Ltd, reducing its beneficial ownership to zero.

Todd W. Fennell has reported beneficial ownership of approximately 10.2% of Prothena Corp's ordinary shares, primarily through various trusts.

Gores Sponsor XI LLC, AEG Holdings, LLC, and Alec Gores collectively hold a 20.3% stake in Gores Holdings XI, Inc., comprising Class A and convertible Class B shares.

Millennium Management LLC, along with affiliated entities and Israel A. Englander, has reported beneficial ownership of 5.8% of Tenax Therapeutics, Inc. common stock.

Voss Capital and affiliated entities have reported beneficial ownership of 12,700,000 ordinary shares, representing 5.1% of Cellebrite DI Ltd.'s outstanding stock.

Intracoastal Capital LLC, along with individuals Mitchell P. Kopin and Daniel B. Asher, have reported beneficial ownership of 4.99% of Silexion Therapeutics Corp. ordinary shares.

Soleus Capital entities and Guy Levy have filed a joint Schedule 13G statement, reporting beneficial ownership of 5.8% of Processa Pharmaceuticals, Inc. common stock.

PSB Financial, Inc. Employee Stock Ownership Plan Trust reports a beneficial ownership of 137,540 shares, representing 8.0% of the company's common stock as of June 30, 2026.

BJI Financial Group has filed a Schedule 13G, reporting beneficial ownership of 6.85% of C1 Fund Inc.'s common stock as of August 18, 2026.